Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Boy Killed in Pedestrian Crash on Hazel Avenue


Teen Hit By Vehicle in Fatal Orangevale Accident 

Orangevale, CA (April 10, 2020) – A teen was killed in a pedestrian crash in Orangevale. The fatal accident occurred on the morning of April 10 on Hazel Avenue.

A teen boy ran out onto Hazel Avenue, near Oak Avenue. He was hit by a vehicle driven by a 45-year-old man. The boy died at the accident scene. The crash is under investigation.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Orangevale

#95662


October 21, 2019

9 Injured in Crash at Sherman Way and De Soto Avenue

WSS Store Flooded in Multi-Vehicle Accident in Los Angeles Los Angeles, CA (Oct...


October 24, 2019

Man Injured in Crash at 14th and Madison Streets

Victim Hit by Shuttle Bus in Oakland Accident Oakland, CA (October 23, 2019) ...


December 11, 2019

Bicyclist Killed in Crash on Highway 111

Van Hits Man in Fatal Calexico Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.